Carl Zeiss revenue increases 12.1%

evenue of €758.8m in financial year 2010/2011, compared to €676.7m the previous year. This corresponds to an increase of 12.1 per cent at the close of its financial year ending 30 September 2011.

“Despite the adverse general economic situation we have been able to continue our growth course and even exceed our expectations,†says Dr Ludwin Monz, president and CEO of Carl Zeiss Meditec AG.

“Although we continued to invest in new products, and to establish and expand our sales and service structures, we have succeeded in increasing profitability. This is not least because we managed to further improve the manufacturing cost position,†said Dr Monz.